Investment Analysts’ Recent Ratings Changes for McKesson (MCK)

A number of research firms have changed their ratings and price targets for McKesson (NYSE: MCK):

• 10/17/2026 – McKesson was upgraded by Wall Street Zen from “hold” to “buy”.
• 10/16/2026 – McKesson had its price target raised by UBS Group AG from $1,080.00 to $1,200.00. They now have a “buy” rating on the stock.
• 10/7/2026 – McKesson had its price target raised by Leerink Partners from $1,030.00 to $1,070.00. They now have an “outperform” rating on the stock.
• 10/6/2026 – McKesson was given a new $977.00 price target by Morgan Stanley.
• 9/14/2026 – McKesson had its “sector perform” rating reaffirmed by Royal Bank Of Canada. They now have a $845.00 price target on the stock.
• 9/4/2026 – McKesson was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”.
• 9/3/2026 – McKesson had its price target raised by Argus from $850.00 to $970.00. They now have a “buy” rating on the stock.

Insider Buying and Selling

In related news, Director Bradley Lerman sold 301 shares of the business’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $892.33, for a total value of $268,591.33. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO B Jr sold 111 shares of the business’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total transaction of $98,950.95. Following the completion of the sale, the chief accounting officer owned 521 shares in the company, valued at approximately $464,445.45. This trade represents a 17.56% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 1,212 shares of company stock valued at $1,164,182. 0.06% of the stock is currently owned by insiders.

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.